Affordable Access

Vitamin K-dependent procoagulant in cancer cells: a potential target for the antimetastatic effect of warfarin?

Authors
  • Donati, M B
  • Roncaglioni, M C
  • Falanga, A
  • Casali, B
  • Semeraro, N
Type
Published Article
Journal
Haemostasis
Publication Date
Jan 01, 1986
Volume
16
Issue
3-4
Pages
288–294
Identifiers
PMID: 3530903
Source
Medline
License
Unknown

Abstract

Anticoagulants of the coumarin type have long been reported to inhibit metastasis growth in experimental animals; however, the mechanisms of such effects has not been clarified. Systemic anticoagulation per se does not appear to account completely for such metastasis growth depression. More recent information gathered on a cell procoagulant activity, which is vitamin K-dependent, could probably supply a fresh insight into this problem. Indeed, vitamin K deficiency induced either dietarily or pharmacologically by warfarin, does inhibit the activity of a cysteine protease with direct factor-X-activating properties. This protease is only present in warfarin-sensitive tumors. The correlation of this activity with cancer cell invasiveness is supported by experimental data in metastatic variants and, lately, also by the observation of markedly higher cancer procoagulant activity in extracts from metastases than from primary human melanomas.

Report this publication

Statistics

Seen <100 times